Skip to main content
Benefit-risk profiles of lasmiditan, rimegepant, and ubrogepant for acute treatment of migraine
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Benefit-risk profiles of lasmiditan, rimegepant, and ubrogepant for acute treatment of migraine
User login
Username
Password
Reset your password
Concept
Lead
score
Migraine
1
1
Pain
0
0.8
Pain Management
0
0.56
Dizziness
0
0.4
Nausea
0
0.4
Meta-Analysis
0
0.2
Specialty
Lead
score
Neurology & Neurosurgery
1
1
Family Medicine/Primary Care
0
1
Edit Tags